ifn alpha beta receptor Search Results


94
Miltenyi Biotec anti ifnar2
Anti Ifnar2, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/IFNAR2+Antibody%2C+anti-human%2C+REAfinity/bio_rxiv__688440-82-24-26
Average 94 stars, based on 1 article reviews
anti ifnar2 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
Proteintech anti ifnar1
Anti Ifnar1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/IFNAR1+Antibody/pmc13031871-497-26-28
Average 93 stars, based on 1 article reviews
anti ifnar1 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Proteintech rabbit anti ifnar2 pab
Rabbit Anti Ifnar2 Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/IFNAR2+Antibody/pmc06146802-340-0-6
Average 93 stars, based on 1 article reviews
rabbit anti ifnar2 pab - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
PBL Assay monoclonal mouse anti human ifnar2
Monoclonal Mouse Anti Human Ifnar2, supplied by PBL Assay, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/Anti-Human+Interferon+Alpha-Beta+Receptor+Chain+2%2C+Clone+MMHAR-2/pmc07068396-52-11-15
Average 96 stars, based on 1 article reviews
monoclonal mouse anti human ifnar2 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

93
MedChemExpress mouse ifnar1
Mouse Ifnar1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/IFNAR1%2C+Mouse/pmc11711403-275-0-7
Average 93 stars, based on 1 article reviews
mouse ifnar1 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
MedChemExpress infar1 inhibitor ifn alpha ifnar
Infar1 Inhibitor Ifn Alpha Ifnar, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/IFN-alpha%2Fbeta+R2%2C+Mouse/pmc10813565-74-20-27
Average 94 stars, based on 1 article reviews
infar1 inhibitor ifn alpha ifnar - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

91
Boster Bio rabbit anti human ifn γ
Rabbit Anti Human Ifn γ, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/Anti-Phospho-Interferon-alpha+Receptor%2C+Type+I%2C+Subunit+1+(Ser535%2C539)+Antibody/pmc04519283-67-52-58
Average 91 stars, based on 1 article reviews
rabbit anti human ifn γ - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

93
Boster Bio gpx4
The primers involved in this study.
Gpx4, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/Anti-Glutathione+Peroxidase+4%2FGPX4+Antibody+Picoband/pmc11004413-23-0-4
Average 93 stars, based on 1 article reviews
gpx4 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
PBL Biomedical Laboratories mouse anti-human mab against ifn- r chain 2
The primers involved in this study.
Mouse Anti Human Mab Against Ifn R Chain 2, supplied by PBL Biomedical Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/neutralizing+mouse+anti+human+ifn+%CE%B1+%CE%B2+receptor+chain+2++cd118++antibody/pm12707322-73-1-33
Average 90 stars, based on 1 article reviews
mouse anti-human mab against ifn- r chain 2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Merck KGaA neutralizing anti-human ifn alpha/beta receptor chain 2 (cd118) mab
The primers involved in this study.
Neutralizing Anti Human Ifn Alpha/Beta Receptor Chain 2 (Cd118) Mab, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/neutralizing+anti+human+ifn+alpha+beta+receptor+chain+2++cd118++mab/pmc07544099-191-8-17
Average 90 stars, based on 1 article reviews
neutralizing anti-human ifn alpha/beta receptor chain 2 (cd118) mab - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson type ifn-α/β receptor antibody
Stop and SuperStop protect against challenge infection. Sera from mice infected with WT, Stop, or SS virus or mock infected with PBS (WT-s, Stop-s, SS-s, or PBS-s) were transferred to C57BL/6 mice that had previously received <t>type</t> <t>I</t> <t>IFN-α/β</t> receptor antibody and were challenged with WT CHIKV. (A) Survival after challenge of mice ( n = 5). *, P = 0.0116 (Kaplan-Meyer with Mantel-Cox test). (B) Weight change after challenge. Values are means with standard errors of the means ( n = 5). Day 4 WT-s *, P = 0.0174; day 4 Stop-s *, P = 0.0218; day 4 SS-s **, P = 0.098; day 5 WT-s **, P = 0.0068; day 5 SS-s *, P = 0.0198; day 6, WT-s **, P = 0.0016; day 6 SS-s *, P = 0.0187 (two-way analysis of variance with Tukey’s multiple-comparison test). (C) Viremia was measured at days 1, 3, 4, 5, 7, and 9 postchallenge. Values are means with standard errors of the means ( n = 5). For days 1, 3, 4, 5 and 7, values for WT-s, Stop-s, and SS-s were significantly different from the value for PBS-s (****, P < 0.0001) (two-way ANOVA with Tukey’s multiple-comparison test). (D) Footpad swelling at days 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 17, 21, 25, and 34 postchallenge. Values are means with standard errors of the means ( n = 5). Values for WT-s, Stop-s, and SS-s were significantly different from the value for PBS-s at days 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 17, and 21 (****, P < 0.0001) and at day 25 (*, P < 0.05) (two-way analysis of variance with Tukey’s multiple-comparison test). (E) Neutralizing antibody titers for individual serum samples and pooled (p) sera (used in passive transfer) from mice infected with WT (WT-p), Stop (Stop-p), and SS (SS-p) virus and mock infected with PBS (PBS-p). Values are means with standard errors of the means ( n = 5). Differences in the values for Stop-s ( P = 0.3210) and SS-s ( P = 0.1335) were nonsignificant ( P > 0.05) relative to values for WT-s. ****, P < 0.0001 (one-way analysis of variance with Tukey’s multiple-comparison test). For pooled sera ( n = 1), no statistical tests were performed.
Type Ifn α/β Receptor Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/type+ifn+%CE%B1+%CE%B2+receptor+antibody/pmc06714818-270-5-10
Average 90 stars, based on 1 article reviews
type ifn-α/β receptor antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Genentech inc ifn-α/β receptor-deficient mice
Stop and SuperStop protect against challenge infection. Sera from mice infected with WT, Stop, or SS virus or mock infected with PBS (WT-s, Stop-s, SS-s, or PBS-s) were transferred to C57BL/6 mice that had previously received <t>type</t> <t>I</t> <t>IFN-α/β</t> receptor antibody and were challenged with WT CHIKV. (A) Survival after challenge of mice ( n = 5). *, P = 0.0116 (Kaplan-Meyer with Mantel-Cox test). (B) Weight change after challenge. Values are means with standard errors of the means ( n = 5). Day 4 WT-s *, P = 0.0174; day 4 Stop-s *, P = 0.0218; day 4 SS-s **, P = 0.098; day 5 WT-s **, P = 0.0068; day 5 SS-s *, P = 0.0198; day 6, WT-s **, P = 0.0016; day 6 SS-s *, P = 0.0187 (two-way analysis of variance with Tukey’s multiple-comparison test). (C) Viremia was measured at days 1, 3, 4, 5, 7, and 9 postchallenge. Values are means with standard errors of the means ( n = 5). For days 1, 3, 4, 5 and 7, values for WT-s, Stop-s, and SS-s were significantly different from the value for PBS-s (****, P < 0.0001) (two-way ANOVA with Tukey’s multiple-comparison test). (D) Footpad swelling at days 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 17, 21, 25, and 34 postchallenge. Values are means with standard errors of the means ( n = 5). Values for WT-s, Stop-s, and SS-s were significantly different from the value for PBS-s at days 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 17, and 21 (****, P < 0.0001) and at day 25 (*, P < 0.05) (two-way analysis of variance with Tukey’s multiple-comparison test). (E) Neutralizing antibody titers for individual serum samples and pooled (p) sera (used in passive transfer) from mice infected with WT (WT-p), Stop (Stop-p), and SS (SS-p) virus and mock infected with PBS (PBS-p). Values are means with standard errors of the means ( n = 5). Differences in the values for Stop-s ( P = 0.3210) and SS-s ( P = 0.1335) were nonsignificant ( P > 0.05) relative to values for WT-s. ****, P < 0.0001 (one-way analysis of variance with Tukey’s multiple-comparison test). For pooled sera ( n = 1), no statistical tests were performed.
Ifn α/β Receptor Deficient Mice, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ifn+alpha+beta+receptor/ifn+%CE%B1+%CE%B2+receptor+deficient+mice/pmc00545555-49-2-12
Average 90 stars, based on 1 article reviews
ifn-α/β receptor-deficient mice - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


The primers involved in this study.

Journal: Poultry Science

Article Title: New insights into the spleen injury by mitochondrial dysfunction of chicken under polystyrene microplastics stress

doi: 10.1016/j.psj.2024.103674

Figure Lengend Snippet: The primers involved in this study.

Article Snippet: GPX4 , 1:500 , Boster Biotechnology, China , A02059-1.

Techniques:

The antibodies used in this study.

Journal: Poultry Science

Article Title: New insights into the spleen injury by mitochondrial dysfunction of chicken under polystyrene microplastics stress

doi: 10.1016/j.psj.2024.103674

Figure Lengend Snippet: The antibodies used in this study.

Article Snippet: GPX4 , 1:500 , Boster Biotechnology, China , A02059-1.

Techniques:

MPs induced ferroptosis in spleen. (A) Western Blot results in ferroptosis-related proteins. (B) Quantitative analysis of GPX4, FTH1, and SLC7A11 protein expression. (C) Ferroptosis-related factors of mRNA expression changes. Data were expressed as mean ± SD, n = 3. *, **, ***, denotes: p < 0.05, 0.01, and 0.001, respectively.

Journal: Poultry Science

Article Title: New insights into the spleen injury by mitochondrial dysfunction of chicken under polystyrene microplastics stress

doi: 10.1016/j.psj.2024.103674

Figure Lengend Snippet: MPs induced ferroptosis in spleen. (A) Western Blot results in ferroptosis-related proteins. (B) Quantitative analysis of GPX4, FTH1, and SLC7A11 protein expression. (C) Ferroptosis-related factors of mRNA expression changes. Data were expressed as mean ± SD, n = 3. *, **, ***, denotes: p < 0.05, 0.01, and 0.001, respectively.

Article Snippet: GPX4 , 1:500 , Boster Biotechnology, China , A02059-1.

Techniques: Western Blot, Expressing

Stop and SuperStop protect against challenge infection. Sera from mice infected with WT, Stop, or SS virus or mock infected with PBS (WT-s, Stop-s, SS-s, or PBS-s) were transferred to C57BL/6 mice that had previously received type I IFN-α/β receptor antibody and were challenged with WT CHIKV. (A) Survival after challenge of mice ( n = 5). *, P = 0.0116 (Kaplan-Meyer with Mantel-Cox test). (B) Weight change after challenge. Values are means with standard errors of the means ( n = 5). Day 4 WT-s *, P = 0.0174; day 4 Stop-s *, P = 0.0218; day 4 SS-s **, P = 0.098; day 5 WT-s **, P = 0.0068; day 5 SS-s *, P = 0.0198; day 6, WT-s **, P = 0.0016; day 6 SS-s *, P = 0.0187 (two-way analysis of variance with Tukey’s multiple-comparison test). (C) Viremia was measured at days 1, 3, 4, 5, 7, and 9 postchallenge. Values are means with standard errors of the means ( n = 5). For days 1, 3, 4, 5 and 7, values for WT-s, Stop-s, and SS-s were significantly different from the value for PBS-s (****, P < 0.0001) (two-way ANOVA with Tukey’s multiple-comparison test). (D) Footpad swelling at days 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 17, 21, 25, and 34 postchallenge. Values are means with standard errors of the means ( n = 5). Values for WT-s, Stop-s, and SS-s were significantly different from the value for PBS-s at days 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 17, and 21 (****, P < 0.0001) and at day 25 (*, P < 0.05) (two-way analysis of variance with Tukey’s multiple-comparison test). (E) Neutralizing antibody titers for individual serum samples and pooled (p) sera (used in passive transfer) from mice infected with WT (WT-p), Stop (Stop-p), and SS (SS-p) virus and mock infected with PBS (PBS-p). Values are means with standard errors of the means ( n = 5). Differences in the values for Stop-s ( P = 0.3210) and SS-s ( P = 0.1335) were nonsignificant ( P > 0.05) relative to values for WT-s. ****, P < 0.0001 (one-way analysis of variance with Tukey’s multiple-comparison test). For pooled sera ( n = 1), no statistical tests were performed.

Journal: Journal of Virology

Article Title: Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated In Vivo and Have Compromised Transmissibility

doi: 10.1128/JVI.00775-19

Figure Lengend Snippet: Stop and SuperStop protect against challenge infection. Sera from mice infected with WT, Stop, or SS virus or mock infected with PBS (WT-s, Stop-s, SS-s, or PBS-s) were transferred to C57BL/6 mice that had previously received type I IFN-α/β receptor antibody and were challenged with WT CHIKV. (A) Survival after challenge of mice ( n = 5). *, P = 0.0116 (Kaplan-Meyer with Mantel-Cox test). (B) Weight change after challenge. Values are means with standard errors of the means ( n = 5). Day 4 WT-s *, P = 0.0174; day 4 Stop-s *, P = 0.0218; day 4 SS-s **, P = 0.098; day 5 WT-s **, P = 0.0068; day 5 SS-s *, P = 0.0198; day 6, WT-s **, P = 0.0016; day 6 SS-s *, P = 0.0187 (two-way analysis of variance with Tukey’s multiple-comparison test). (C) Viremia was measured at days 1, 3, 4, 5, 7, and 9 postchallenge. Values are means with standard errors of the means ( n = 5). For days 1, 3, 4, 5 and 7, values for WT-s, Stop-s, and SS-s were significantly different from the value for PBS-s (****, P < 0.0001) (two-way ANOVA with Tukey’s multiple-comparison test). (D) Footpad swelling at days 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 17, 21, 25, and 34 postchallenge. Values are means with standard errors of the means ( n = 5). Values for WT-s, Stop-s, and SS-s were significantly different from the value for PBS-s at days 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 17, and 21 (****, P < 0.0001) and at day 25 (*, P < 0.05) (two-way analysis of variance with Tukey’s multiple-comparison test). (E) Neutralizing antibody titers for individual serum samples and pooled (p) sera (used in passive transfer) from mice infected with WT (WT-p), Stop (Stop-p), and SS (SS-p) virus and mock infected with PBS (PBS-p). Values are means with standard errors of the means ( n = 5). Differences in the values for Stop-s ( P = 0.3210) and SS-s ( P = 0.1335) were nonsignificant ( P > 0.05) relative to values for WT-s. ****, P < 0.0001 (one-way analysis of variance with Tukey’s multiple-comparison test). For pooled sera ( n = 1), no statistical tests were performed.

Article Snippet: In parallel, 0.1 mg of type I IFN-α/β receptor antibody (BD Biosciences) was administered to mice by i.p. injection to increase their susceptibility to CHIKV infection.

Techniques: Infection